🩺 A new drug for schizophrenia, called Cobenfy, has been developed by US pharma giant Bristol Myers Squibb, and approved September 27. The drug works differently from existing treatments, targeting the so-called cholinergic receptors, not the dopamine receptors.

New drug for schizophrenics has experts excited

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades.